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Non-insulinoma pancreatogenous hypoglycaemia syndrome is a rare cause of spontaneous hypoglycaemia in adults. There are few case reports and most of these involve a history of bariatric surgery and are characterized by post-prandial hypoglycaemia 1,2 . Poor understanding of the pathogenesis of this condition precludes a clear diagnostic approach and limits treatment options 1 . Here we present a case of hypoglycaemia with no previous bariatric surgery and our treatment strategy.
References
The patient is a 62 year old gentleman with a background of Marfan's Syndrome, who presented with episodic hypoglycaemia over a period of 22 years. Of note he was not diabetic and was not on any hypoglycaemiainducing medications. His past medical history and medications at present include:
There are some reports in the literature suggesting a role for GLP-1 agonists in the management of post-prandial hypoglycaemia. The patient was therefore initially trialled on liraglutide 0.6mg OD but despite a dose increase, this failed to significantly impact on severity or frequency of hypoglycaemic episodes.
There are similar reports supporting the use of somatostatin antagonists and so the patient was next commenced on octreotide 50mcg QDS. This produced a dramatic improvement as shown in the graphs, but unfortunately the patient developed tachyphylaxis and this effect wore off with time.
At this time a further 72 hours fast did reveal an element of fasting hypoglycaemia and so insulin and C-peptide were repeated as well as pancreatic imaging although these did not reveal any abnormality. This patient's investigations are suggestive of non-insulinoma pancreatogenous hypoglycaemia (NIPH). Differentials would include insulinoma, insulin auto-antibody syndrome. The pathogenesis of NIPH is unclear but proposed mechanisms include GLP-induced beta cell hyperplasia 1, 4 . Genetic associations with genes affecting insulin secretion have also been reported 5 .
Similarly, there is conflicting evidence as to the best treatment for NIPH. Both Diazoxide and Octreotide have been used with variable success in the case reports [1] [2] [3] 6 . This case report lends support to the use of octreotide albeit with the disadvantage of tachyphylaxis. This case report also supports the use of prednisolone and diazoxide but again with the limitations of various adverse effects.
This case report also highlights a possible association between hypoglycaemia and cardiac arrhythmia as has previously been suggested in type 2 diabetes 7 . It is interesting to speculate whether his atrial fibrillation, complete heart block and ventricular tachycardia were all in fact induced by hypoglycaemia. Clearly further work is needed to investigate this association. 
A Case Of Hypoglycaemia
Multiple 72hr fasts and continuous blood glucose monitoring failed to reveal any fasting hypoglycaemia. An OGTT did reveal however a symptomatic hypoglycaemia of glucose of 2.4mmol/L at 2.5 hrs following a glucose load. Basic biochemistry, hormone profiles (LH, FSH, testosterone, TFTs, ACTH, SST, cortisol, GH, IGF-1, urinary metanephrines), sulphonylurea screen and insulin-auto-antibodies were normal. At a blood glucose of 3.0, c-peptide was raised at 1336pmol/L, and insulin was normal at 21 pmol/L although the sample was haemolysed which may result for the falsely low insulin level.
The patient was initially given dietetic input including advice on eating foods with low glycaemic indexes and was started on acarbose. This did improve the frequency of episodes but they still continued to occur regularly.
A metabolic screen at this time including Beta-hydroxybutyrate, free fatty acids, organic acids, amino acids and genetic screening for common mutations was also negative. • Paroxysmal atrial fibrillation
This gentleman initially presented to Cardiology Clinic in 2001 due to episodes of syncope, palpitations, sweating and blackout. Over the subsequent years he had a permanent pacemaker inserted for complete heart block; an ICD inserted for episodes of ventricular tachycardia; and beta blockers for a dilated aortic root. He was additionally found to have atrial fibrillation and was started on metoprolol and fleicanide for this. Whilst his symptoms did somewhat improve, he continued to have similar episodes and this was initially attributed to druginduced postural hypotension.
He eventually presented to the emergency department with symptoms as above and was found to be profoundly hypoglycaemic with a blood glucose of 1.3 mmol/L and his symptoms were treated successfully by correcting this hypoglycaemia and was referred to endocrinology.
• Metoprolol 25mg tds
Despite an increase in dose of octreotide and treatment breaks, tachyphylaxis remained an issue with the use of octreotide. The patient was therefore started on prednisolone and diazoxide in place of octreotide. Whilst effective, diazoxide did have the side effect of hypotension, but attempts are currently ongoing to accommodate for diazoxide by a reduction in metoprolol and fleicanide. The aim would be the minimise the prednisolone dose by increasing diazoxide.
Current Regime-Diazoxide 100mg TDS, Prednisolone 10mg 
Investigation and Treatment
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The patient is a 62 year old gentleman who presented with episodic hypoglycaemia extending over a period of 22 years. His past medical history and medications at present include:
The patient was initially trialled on liraglutide 0.6mg OD but despite a dose increase, this failed to significantly impact on severity or frequency of hypoglycaemic episodes.
The patient was next commenced on octreotide 50mcg QDS. This produced a dramatic improvement as shown in the graphs, but unfortunately the patient developed tachyphylaxis and this beneficial effect diminished with time.
This patient's investigations are suggestive of non-insulinoma pancreatogenous hypoglycaemia (NIPH). Differentials include insulinoma and insulin auto-antibody syndrome. The pathogenesis of NIPH is unclear but proposed mechanisms include GLP-1 induced beta cell hyperplasia 1,4 . Genetic associations with genes affecting insulin secretion have also been reported 5 . Similarly, there is conflicting evidence as to the best treatment for NIPH. Both Diazoxide and Octreotide have been used with variable success in the case reports [1] [2] [3] 6 .This case report lends support to the use of octreotide albeit with the disadvantage of tachyphylaxis. This case report also supports the use of prednisolone and diazoxide but again with the limitations of various adverse effects.
This case report also highlights a possible association between hypoglycaemia and cardiac arrhythmia as has previously been suggested in type 2 diabetes 7 . It is interesting to speculate whether his atrial fibrillation, complete heart block and ventricular tachycardia were all in fact induced by hypoglycaemia. Clearly further work is needed to investigate this association. A Case Of Hypoglycaemia 72hr fasts and continuous blood glucose monitoring initially failed to reveal any fasting hypoglycaemia. A 5 hr OGTT did reveal however a nadir glucose of 2.4mmol/L at 2.5 hrs following a 75g glucose load. Basic biochemistry, hormone profiles (LH, FSH, testosterone, TFTs, ACTH, SST, cortisol, GH, IGF-1, urinary metanephrines), and sulphonylurea screen were normal.
Initial management was with advice on eating foods with a low glycaemic index and with the use of acarbose. This reduced the frequency of episodes but they still continued to occur regularly.
A metabolic screen at this time including Beta-hydroxybutyrate, free fatty acids, organic acids, amino acids and genetic screening for common mutations was also negative.
Further 72 hours fast and continuous blood glucose monitoring also revealed an element of fasting hypoglycaemia. At a blood glucose of 3.0 mmol/L c-peptide was measured at 1336pmol/L (<1030pmol/L), and insulin 21 pmol/L(<174pmol/L) (although the sample was haemolysed which may result in falsely lower insulin levels). Pancreatic imaging did not reveal any abnormality. He eventually presented to the emergency department with symptoms as above and was found to be profoundly hypoglycaemic (Whipple's triad present) with a capillary blood glucose of 1.3 mmol/L and was referred to endocrinology.
• Despite an increase in dose of octreotide and treatment breaks, tachyphylaxis remained an issue with the use of octreotide. The patient was therefore started on prednisolone and diazoxide in place of octreotide. Whilst effective, diazoxide did have the side effect of hypotension, but attempts are currently ongoing to accommodate for diazoxide by a reduction in metoprolol and fleicanide. The current regime is diazoxide 100mg TDS and prednisolone 10mg OD. 
